Who should receive extended infusion beta-lactam therapy?

Authors

Christopher Roman
Tia Solh, Philadelphia College of Osteopathic MedicineFollow
Kendra M. Damer

Document Type

Article

Publication Date

2016

Abstract

The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.

Publication Title

Journal of the American Academy of Physician Assistants

Volume

29

Issue

3

First Page

25

Last Page

26

Comments

This article was published in Journal of the American Academy of Physician Assistants, Volume 29, Issue 3, Pages 25-26.

The published version is available at http://dx.doi.org/10.1097/01.JAA.0000480576.16121.88.

Copyright © 2016 LWW.

Recommended Citation

Roman, Christopher; Solh, Tia; and Damer, Kendra M., "Who should receive extended infusion beta-lactam therapy?" (2016). PCOM Scholarly Papers. 1649.
https://digitalcommons.pcom.edu/scholarly_papers/1649